
Announcement of the 47th ISOBM Conference
On behalf of the Board of Directors of the International Society of Oncology and Biomarkers (ISOBM), we are pleased to provide you with initial information about the Annual Conference 2025:
The focus of this Conference will be on biomarker research and its clinical application, molecular diagnostics, technological breakthroughs and artificial intelligence leading to a “New Era of Biomarkers in Oncology” and improving diagnosis, therapy monitoring and patient care through the course of cancer disease.
The Conference aims to bring together leading academic scientists, young and experienced researchers, medical clinicians and technology specialists from all fields of oncology to exchange and share their research results and experiences with emphasis on new biomarkers, technologies and applications in cancer care.
Oral and poster presentations, roundtable discussions and special topic seminars, workshops and room for interaction with colleagues and industry partners will provide new insights, constructive discussions and opportunities for networking and further collaborations.

Prof. Stefan Holdenrieder
Conference President
Key Topics of the Conference

Key topics of the conference include:
- Molecular pathology and blood-based biomarkers
- Liquid profiling/liquid biopsy
ctDNA, CTCs, epigenetics, fragmentomics - Protein-based markers, tumor markers
- Extracellular vesicles and associated markers
- Immune diagnostics
- Proteomics and metabolomics
- Technological breakthroughs
- Evidence-based medicine (EBM)
- Standardization and harmonization
- Biomarkers for solid and hematological cancers
- Early cancer detection and screening
- Prognostic and predictive biomarkers
- Monitoring of therapy response and toxicity
- Targeted and immune therapies, cancer vaccines
- Imaging technologies
- Advanced biostatistics and algorithms
- Artificial intelligence and machine learning
- Clinical biomarker trials
- Biobanking and sample collections
- Personalized medicine
You will find more information on this page soon.
Conference Location

The conference will take place at the Culture and Conference Center in Murnau near Munich. The culture and conference centre with its extraordinary architecture offers a spacious atmosphere on two event levels.
Culture and Conference Center Murnau
Ödön-von-Horváth-Platz 1
82418 Murnau a. Staffelsee
ISOBM 2025 - Information on Sponsorship
The symposium is supported by industry.
If you are interested in supporting the conference as a sponsor, please contact us at
Organizer
International Society of Oncology and Biomarkers (ISOBM)
14 City Quay
DDI 3JA Dundee
UK
represented by its President
Prof. Dr. Stefan Holdenrieder
Conference Agency
Trillium GmbH Medizinischer Fachverlag
Jesenwanger Str. 42 b
82284 Grafrath
Germany